Min Luo

10PUBLICATIONS
32CO-AUTHORS
Innate immunityMolecular targetsTumour immunologyMedical infection agents (incl. prions)Proteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 15, 2026
CD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8+ T cells.

|Apr 14, 2026
Tumor-derived branched-chain α-keto acids activate Notch signaling in tumor-associated macrophages to limit immunity.

Qi-Xiang Ma, Ru Zhao, Jiang-Xue Han

|Mar 30, 2026
Dual function of DOT1L suppresses tumor cell-intrinsic immunogenicity in hepatocellular carcinoma.

Siyuan Xu, Ruijie Gong, Songchen Liu

|Mar 10, 2026
Amphotericin B promotes respiratory viral entry by enhancing late endosomal maturation and fusion via glucocerebrosidase-mediated ceramide remodeling.

Di He, Wenting Zuo, Zhiguang Xiang

|Jan 16, 2026
CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors.

Xianglei Wang, Shiyao Xue, Yuwei Li

|Apr 09, 2025
MYO1F in neutrophils is required for the response to immune checkpoint blockade therapy.

Yingying Qu, Wenhua Liang, Mingzhu Yu

Pageof 2

Frequent Collaborators

3 joint publications

Zhigang Lu

2 joint publications

Peixuan Zheng

2 joint publications

Yun Zhao

1 joint publications

Hai Gao